Literature DB >> 21585422

Role of mineralocorticoid action in the brain in salt-sensitive hypertension.

Kenji Oki1, Elise P Gomez-Sanchez, Celso E Gomez-Sanchez.   

Abstract

1. The mechanisms by which excessive salt causes hypertension involve more than retention of sodium and water by the kidneys and are far from clear. Mineralocorticoids act centrally to increase salt appetite, sympathetic drive and vasopressin release, resulting in hypertension that is prevented by the central infusion of mineralocorticoid receptor (MR) antagonists. The MR has similar affinity for aldosterone and the glucocorticoids corticosterone or cortisol. Specificity is conferred in transport epithelia by the colocalization of the MR with 11β-hydroxysteroid dehydrogenase Type 2. Coexpression also occurs in some neurons, notably those of the nucleus tractus solitarius that are activated by sodium depletion and aldosterone and mediate salt-seeking behaviour. 2. The salt-induced hypertension of the Dahl salt-sensitive rat is mitigated by the central infusion of a mineralocorticoid antagonist even though circulating aldosterone is normal or reduced in salt-sensitive (SS). Contrary to reports that salt appetite in the Dahl salt-sensitive rat is depressed, we found that it is increased compared with that in Spraque-Dawley rats. 3. Extra-adrenal aldosterone synthesis in the brain occurs in minute amounts that could only be relevant locally. Expression of aldosterone synthase mRNA and aldosterone concentrations in the brain of Dahl salt-sensitive rats are increased compared with Spraque-Dawley rats. The central infusion of inhibitors of aldosterone synthesis lowers salt-induced hypertension in the Dahl salt-sensitive rat, suggesting a role for excessive Dahl salt-sensitive synthesis in the brain. Brain MR, particularly those in the paraventricular nuclei, regulate inflammatory processes that are exacerbated by sodium and lead to cardiovascular dysfunction.
© 2011 The Authors. Clinical and Experimental Pharmacology and Physiology © 2011 Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21585422      PMCID: PMC3164934          DOI: 10.1111/j.1440-1681.2011.05538.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  76 in total

1.  Mineralocorticoid receptor blockade but not steroid withdrawal reverses renal fibrosis in deoxycorticosterone/salt rats.

Authors:  Emily Y M Lam; John W Funder; David J Nikolic-Paterson; Peter J Fuller; Morag J Young
Journal:  Endocrinology       Date:  2006-04-20       Impact factor: 4.736

2.  Development of a panel of monoclonal antibodies against the mineralocorticoid receptor.

Authors:  Celso E Gomez-Sanchez; Angela F de Rodriguez; Damian G Romero; Justin Estess; Mary P Warden; Miriam T Gomez-Sanchez; Elise P Gomez-Sanchez
Journal:  Endocrinology       Date:  2005-11-17       Impact factor: 4.736

3.  Distribution of epithelial sodium channels and mineralocorticoid receptors in cardiovascular regulatory centers in rat brain.

Authors:  Md Shahrier Amin; Hong-Wei Wang; Erona Reza; Stewart C Whitman; Balwant S Tuana; Frans H H Leenen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-09-01       Impact factor: 3.619

4.  Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria.

Authors:  Marcus Quinkler; Daniel Zehnder; Kevin S Eardley; Julia Lepenies; Alexander J Howie; Susan V Hughes; Paul Cockwell; Martin Hewison; Paul M Stewart
Journal:  Circulation       Date:  2005-09-06       Impact factor: 29.690

5.  Novel effect of mineralocorticoid receptor antagonism to reduce proinflammatory cytokines and hypothalamic activation in rats with ischemia-induced heart failure.

Authors:  Yu-Ming Kang; Zhi-Hua Zhang; Ralph F Johnson; Yang Yu; Terry Beltz; Alan Kim Johnson; Robert M Weiss; Robert B Felder
Journal:  Circ Res       Date:  2006-09-07       Impact factor: 17.367

6.  Aldosterone impairs baroreflex sensitivity in healthy adults.

Authors:  Kevin D Monahan; Urs A Leuenberger; Chester A Ray
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-08-18       Impact factor: 4.733

7.  Increased number of aldosterone-sensitive NTS neurons in Dahl salt-sensitive rats.

Authors:  Joel C Geerling; Sunitha M Sequeira; Arthur D Loewy
Journal:  Brain Res       Date:  2005-11-28       Impact factor: 3.252

Review 8.  The mineralocorticoid receptor and oxidative stress.

Authors:  Anette Fiebeler; Friedrich C Luft
Journal:  Heart Fail Rev       Date:  2005-01       Impact factor: 4.214

9.  Chronic central infusion of aldosterone leads to sympathetic hyperreactivity and hypertension in Dahl S but not Dahl R rats.

Authors:  Bing S Huang; Hao Wang; Frans H H Leenen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-09-30       Impact factor: 4.733

10.  Effect of 3beta-hydroxysteroid dehydrogenase inhibition by trilostane on blood pressure in the Dahl salt-sensitive rat.

Authors:  Elise P Gomez-Sanchez; Jacqueline Samuel; Gaston Vergara; Naveed Ahmad
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-09-30       Impact factor: 3.619

View more
  17 in total

Review 1.  Mineralocorticoid Receptors, Neuroinflammation and Hypertensive Encephalopathy.

Authors:  Maria Elvira Brocca; Luciana Pietranera; Edo Ronald de Kloet; Alejandro Federico De Nicola
Journal:  Cell Mol Neurobiol       Date:  2018-08-16       Impact factor: 5.046

2.  The differences in brain stem transcriptional profiling in hypertensive ISIAH and normotensive WAG rats.

Authors:  Larisa A Fedoseeva; Leonid O Klimov; Nikita I Ershov; Vadim M Efimov; Arcady L Markel; Yuriy L Orlov; Olga E Redina
Journal:  BMC Genomics       Date:  2019-05-08       Impact factor: 3.969

Review 3.  Hypercortisolism in obesity-associated hypertension.

Authors:  Amy G Varughese; Oksana Nimkevych; Gabriel I Uwaifo
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

Review 4.  Stress, Genes, and Hypertension. Contribution of the ISIAH Rat Strain Study.

Authors:  Olga E Redina; Arcady L Markel
Journal:  Curr Hypertens Rep       Date:  2018-06-16       Impact factor: 5.369

Review 5.  Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis.

Authors:  Nancy J Brown
Journal:  Nat Rev Nephrol       Date:  2013-06-18       Impact factor: 28.314

6.  A mutation in the start codon of γ-crystallin D leads to nuclear cataracts in the Dahl SS/Jr-Ctr strain.

Authors:  Ashley C Johnson; Jonathan W Lee; Ashlyn C Harmon; Zaliya Morris; Xuexiang Wang; Jonathan Fratkin; John P Rapp; Elise Gomez-Sanchez; Michael R Garrett
Journal:  Mamm Genome       Date:  2013-02-13       Impact factor: 2.957

7.  Angiotensin-converting enzyme inhibitor does not suppress renal angiotensin II levels in angiotensin I-infused rats.

Authors:  Keisuke Ohnishi; Miki Murase; Daisuke Nakano; Nicolas Pelisch; Hirofumi Hitomi; Hiroyuki Kobori; Satoshi Morimoto; Hirohito Mori; Tsutomu Masaki; Koji Ohmori; Masakazu Kohno; Atsuhiro Ichihara; Akira Nishiyama
Journal:  J Pharmacol Sci       Date:  2013-05-22       Impact factor: 3.337

Review 8.  Central nervous system neuroplasticity and the sensitization of hypertension.

Authors:  Alan Kim Johnson; Baojian Xue
Journal:  Nat Rev Nephrol       Date:  2018-12       Impact factor: 28.314

Review 9.  11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

Authors:  Karen Chapman; Megan Holmes; Jonathan Seckl
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

10.  Oxidative stress-induced glomerular mineralocorticoid receptor activation limits the benefit of salt reduction in Dahl salt-sensitive rats.

Authors:  Kento Kitada; Daisuke Nakano; Ya Liu; Yoshihide Fujisawa; Hirofumi Hitomi; Yuki Shibayama; Hirotaka Shibata; Yukiko Nagai; Hirohito Mori; Tsutomu Masaki; Hiroyuki Kobori; Akira Nishiyama
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.